Molecular characterization of the tumor microenvironment in breast cancer

Cancer Cell

Volumn 6, Issue 1, 2004, Pages 17-32

  Allinen, Minna ^a,b   Beroukhim, Rameen ^a,b   Cai, Li ^a   Brennan, Cameron ^a   Lahti Domenici, Jaana ^a   Huang, Haiyan ^a,c,g   Porter, Dale ^a,b   Hu, Min ^a,b   Chin, Lynda ^a,b   Richardson, Andrea ^b,d   Schnitt, Stuart ^b,e   Sellers, William R ^a,b,f   Polyak, Kornelia ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; MESSENGER RNA;

ARTICLE; BREAST; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL GROWTH; CELL MIGRATION; CELL TYPE; DATA ANALYSIS; DNA POLYMORPHISM; GENE EXPRESSION; GENE OVEREXPRESSION; GENOME; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIGAND BINDING; MICROENVIRONMENT; MUTATION; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN SECRETION; STROMA CELL;

EID: 3142512612     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.06.010     Document Type: Article

References (91)

1. Alpaugh M.L., Lee M.C., Nguyen M., Deato M., Dishakjian L., Barsky S.H. Myoepithelial-specific CD44 shedding contributes to the anti-invasive and antiangiogenic phenotype of myoepithelial cells. Exp. Cell Res. 261:2000;150-158
2. Amiel A., Kaufman Z., Goldstein E., Bruchim R.B., Kidron D., Gaber E., Fejgin M.D. Application of comparative genomic hybridization in search for genetic aberrations in fibroadenomas of the breast. Cancer Genet. Cytogenet. 142:2003;145-148
3. Barbero S., Bajetto A., Bonavia R., Porcile C., Piccioli P., Pirani P., Ravetti J.L., Zona G., Spaziante R., Florio T., Schettini G. Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro. Ann. N Y Acad. Sci. 973:2002;60-69
4. Barsky S.H. Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype. Exp. Mol. Pathol. 74:2003;113-122
5. Bhowmick N.A., Chytil A., Plieth D., Gorska A.E., Dumont N., Shappell S., Washington M.K., Neilson E.G., Moses H.L. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science. 303:2004;848-851
6. Bissell M.J., Radisky D. Putting tumours in context. Nat. Rev. Cancer. 1:2001;46-54
7. Bissell M.J., Radisky D.C., Rizki A., Weaver V.M., Petersen O.W. The organizing principle. microenvironmental influences in the normal and malignant breast Differentiation. 70:2002;537-546
8. Bocker W., Moll R., Poremba C., Holland R., Van Diest P.J., Dervan P., Burger H., Wai D., Ina Diallo R., Brandt B., et al. Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages. a new cell biological concept Lab. Invest. 82:2002;737-746
9. Brennan C., Zhang Y., Leo C., Feng B., Cauwels C., Aguirre A.J., Kim M., Protopopov A., Chin L. High-resolution global profiling of genomic alterations with long oligonucleotide microarray. Cancer Res. in press:2004
10. Cai L., Huang H., Blackshaw S., Liu J.S., Cepko C., Wong W.H. Clustering analysis of SAGE data using a Poisson approach. Genome Biol. in press:2004
11. Chauhan H., Abraham A., Phillips J.R., Pringle J.H., Walker R.A., Jones J.L. There is more than one kind of myofibroblast. analysis of CD34 expression in benign, in situ, and invasive breast lesions J. Clin. Pathol. 56:2003;271-276
12. Chen Y., Stamatoyannopoulos G., Song C.Z. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res. 63:2003;4801-4804
13. Coussens L.M., Werb Z. Inflammation and cancer. Nature. 420:2002;860-867
14. DeCosse J.J., Gossens C.L., Kuzma J.F., Unsworth B.R. Breast cancer. induction of differentiation by embryonic tissue Science. 181:1973;1057-1058
15. DeCosse J.J., Gossens C., Kuzma J.F., Unsworth B.R. Embryonic inductive tissues that cause histologic differentiation of murine mammary carcinoma in vitro. J. Natl. Cancer Inst. 54:1975;913-922
16. Deng G., Lu Y., Zlotnikov G., Thor A.D., Smith H.S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science. 274:1996;2057-2059
17. Deugnier M.A., Teuliere J., Faraldo M.M., Thiery J.P., Glukhova M.A. The importance of being a myoepithelial cell. Breast Cancer Res. 4:2002;224-230
18. De Wever O., Mareel M. Role of tissue stroma in cancer cell invasion. J. Pathol. 200:2003;429-447
19. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., Wicha M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17:2003;1253-1270
20. Elenbaas B., Weinberg R.A. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 264:2001;169-184
21. Flanagan J.G., Leder P. The kit ligand. a cell surface molecule altered in steel mutant fibroblasts Cell. 63:1990;185-194
22. Forsti A., Louhelainen J., Soderberg M., Wijkstrom H., Hemminki K. Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer. Eur. J. Cancer. 37:2001;1372-1380
23. Frederick M.J., Henderson Y., Xu X., Deavers M.T., Sahin A.A., Wu H., Lewis D.E., El-Naggar A.K., Clayman G.L. In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am. J. Pathol. 156:2000;1937-1950
24. Gabbiani G. Some historical and philosophical reflections on the myofibroblast concept. Curr. Top. Pathol. 93:1999;1-5
25. Gerard C., Rollins B.J. Chemokines and disease. Nat. Immunol. 2:2001;108-115
26. Gomm J.J., Browne P.J., Coope R.C., Bansal G.S., Yiangou C., Johnston C.L., Mason R., Coombes R.C. A paracrine role for myoepithelial cell-derived FGF2 in the normal human breast. Exp. Cell Res. 234:1997;165-173. a
27. Gomm J.J., Coope R.C., Browne P.J., Coombes R.C. Separated human breast epithelial and myoepithelial cells have different growth factor requirements in vitro but can reconstitute normal breast lobuloalveolar structure. J. Cell. Physiol. 171:1997;11-19. b
28. Gudjonsson T., Ronnov-Jessen L., Villadsen R., Rank F., Bissell M.J., Petersen O.W. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J. Cell Sci. 115:2002;39-50
29. Hall J.M., Korach K.S. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol. Endocrinol. 17:2003;792-803
30. Hromas R., Broxmeyer H.E., Kim C., Nakshatri H., Christopherson K. 2nd, Azam M., Hou Y.H. Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem. Biophys. Res. Commun. 255:1999;703-706
31. Hunter K.W. Host genetics and tumour metastasis. Br. J. Cancer. 90:2004;752-755
32. Ishii G., Sangai T., Oda T., Aoyagi Y., Hasebe T., Kanomata N., Endoh Y., Okumura C., Okuhara Y., Magae J., et al. Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem. Biophys. Res. Commun. 309:2003;232-240
33. Kang Y., Siegel P.M., Shu W., Drobnjak M., Kakonen S.M., Cordon-Cardo C., Guise T.A., Massague J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 3:2003;537-549
34. Kenny P.A., Bissell M.J. Tumor reversion. correction of malignant behavior by microenvironmental cues Int. J. Cancer. 107:2003;688-695
35. Kurose K., Hoshaw-Woodard S., Adeyinka A., Lemeshow S., Watson P.H., Eng C. Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma. clues to tumour-microenvironment interactions Hum. Mol. Genet. 10:2001;1907-1913
36. Kurose K., Gilley K., Matsumoto S., Watson P.H., Zhou X.P., Eng C. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat. Genet. 32:2002;355-357
37. Kurth I., Willimann K., Schaerli P., Hunziker T., Clark-Lewis I., Moser B. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J. Exp. Med. 194:2001;855-861
38. Lakhani S.R., Jacquemier J., Sloane J.P., Gusterson B.A., Anderson T.J., van de Vijver M.J., Farid L.M., Venter D., Antoniou A., Storfer-Isser A., et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J. Natl. Cancer Inst. 90:1998;1138-1145
39. Lakhani S.R., Chaggar R., Davies S., Jones C., Collins N., Odel C., Stratton M.R., O'Hare M.J. Genetic alterations in 'normal' luminal and myoepithelial cells of the breast. J. Pathol. 189:1999;496-503
40. Lander E.S., Green P. Construction of multilocus genetic linkage maps in humans. Proc. Natl. Acad. Sci. USA. 84:1987;2363-2367
41. Lieberfarb M.E., Lin M., Lechpammer M., Li C., Tanenbaum D.M., Febbo P.G., Wright R.L., Shim J., Kantoff P.W., Loda M., et al. Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP. Cancer Res. 63:2003;4781-4785
42. Lin M., Wei L.J., Sellers W.R., Lieberfarb M., Wong W.H., Li C. dChipSNP. significance curve and clustering of SNP-array-based loss-of-heterozygosity data Bioinformatics. 20:2004;1233-1240
43. Lucito R., Healy J., Alexander J., Reiner A., Esposito D., Chi M., Rodgers L., Brady A., Sebat J., Troge J., et al. Representational oligonucleotide microarray analysis. a high-resolution method to detect genome copy number variation Genome Res. 13:2003;2291-2305
44. Maffini M.V., Soto A.M., Calabro J.M., Ucci A.A., Sonnenschein C. The stroma as a crucial target in rat mammary gland carcinogenesis. J. Cell Sci. 117:2004;1495-1502
45. Man Y.G., Tai L., Barner R., Vang R., Saenger J.S., Shekitka K.M., Bratthauer G.L., Wheeler D.T., Liang C.Y., Vinh T.N., Strauss B.L. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features. implications for tumor progression and invasion Breast Cancer Res. 5:2003;R231-R241
46. Matsuzaki H., Loi H., Dong S., Tsai Y.Y., Fang J., Law J., Di X., Liu W.M., Yang G., Liu G., et al. Parallel genotyping of over 10, 000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res. 14:2004;414-425
47. Moinfar F., Man Y.G., Arnould L., Bratthauer G.L., Ratschek M., Tavassoli F.A. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma. implications for tumorigenesis Cancer Res. 60:2000;2562-2566
48. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:2001;50-56
49. Murrell T.G. The potential for oxytocin (OT) to prevent breast cancer. a hypothesis Breast Cancer Res. Treat. 35:1995;225-229
50. Nguyen M., Lee M.C., Wang J.L., Tomlinson J.S., Shao Z.M., Alpaugh M.L., Barsky S.H. The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype. Oncogene. 19:2000;3449-3459
51. Nishizaki T., DeVries S., Chew K., Goodson W.H. 3rd, Ljung B.M., Thor A., Waldman F.M. Genetic alterations in primary breast cancers and their metastases. direct comparison using modified comparative genomic hybridization Genes Chromosomes Cancer. 19:1997;267-272
52. Oh S.J., Kurz H., Christ B., Wilting J. Platelet-derived growth factor-B induces transformation of fibrocytes into spindle-shaped myofibroblasts in vivo. Histochem. Cell Biol. 109:1998;349-357
53. Page M.J., Amess B., Townsend R.R., Parekh R., Herath A., Brusten L., Zvelebil M.J., Stein R.C., Waterfield M.D., Davies S.C., O'Hare M.J. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. Proc. Natl. Acad. Sci. USA. 96:1999;12589-12594
54. Pollack J.R., Perou C.M., Alizadeh A.A., Eisen M.B., Pergamenschikov A., Williams C.F., Jeffrey S.S., Botstein D., Brown P.O. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet. 23:1999;41-46
55. Porter D.A., Krop I.E., Nasser S., Sgroi D., Kaelin C.M., Marks J.R., Riggins G., Polyak K. A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res. 61:2001;5697-5702
56. Porter D., Lahti-Domenici J., Keshaviah A., Bae Y.K., Argani P., Marks J., Richardson A., Cooper A., Strausberg R., Riggins G.J., et al. Molecular markers in ductal carcinoma in situ of the breast. Mol. Cancer Res. 1:2003;362-375. a
57. Porter D., Weremowicz S., Chin K., Seth P., Keshaviah A., Lahti-Domenici J., Bae Y.K., Monitto C.L., Merlos-Suarez A., Chan J., et al. A neural survival factor is a candidate oncogene in breast cancer. Proc. Natl. Acad. Sci. USA. 100:2003;10931-10936. b
58. Radisky D., Hagios C., Bissell M.J. Tumors are unique organs defined by abnormal signaling and context. Semin. Cancer Biol. 11:2001;87-95
59. Rajagopalan H., Nowak M.A., Vogelstein B., Lengauer C. The significance of unstable chromosomes in colorectal cancer. Nat. Rev. Cancer. 3:2003;695-701
60. Ramaswamy S., Ross K.N., Lander E.S., Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33:2003;49-54
61. Rohan R.M., Fernandez A., Udagawa T., Yuan J., D'Amato R.J. Genetic heterogeneity of angiogenesis in mice. FASEB J. 14:2000;871-876
62. Ronnov-Jessen L., Petersen O.W., Koteliansky V.E., Bissell M.J. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J. Clin. Invest. 95:1995;859-873
63. Ronnov-Jessen L., Petersen O.W., Bissell M.J. Cellular changes involved in conversion of normal to malignant breast. importance of the stromal reaction Physiol. Rev. 76:1996;69-125
64. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:2000;217-242
65. Rubin J.B., Kung A.L., Klein R.S., Chan J.A., Sun Y., Schmidt K., Kieran M.W., Luster A.D., Segal R.A. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc. Natl. Acad. Sci. USA. 100:2003;13513-13518
66. Sawyer E.J., Hanby A.M., Ellis P., Lakhani S.R., Ellis I.O., Boyle S., Tomlinson I.P. Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components. Am. J. Pathol. 156:2000;1093-1098
67. Sawyer E.J., Hanby A.M., Rowan A.J., Gillett C.E., Thomas R.E., Poulsom R., Lakhani S.R., Ellis I.O., Ellis P., Tomlinson I.P. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours. J. Pathol. 196:2002;437-444
68. Schena M., Shalon D., Davis R.W., Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 270:1995;467-470
69. Schurch W. The myofibroblast in neoplasia. Curr. Top. Pathol. 93:1999;135-148
70. Scotton C.J., Wilson J.L., Scott K., Stamp G., Wilbanks G.D., Fricker S., Bridger G., Balkwill F.R. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res. 62:2002;5930-5938
71. Shao Z.M., Nguyen M., Alpaugh M.L., O'Connell J.T., Barsky S.H. The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. Exp. Cell Res. 241:1998;394-403
72. Shekhar M.P., Pauley R., Heppner G. Host microenvironment in breast cancer development. extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast Breast Cancer Res. 5:2003;130-135
73. Sleeman M.A., Fraser J.K., Murison J.G., Kelly S.L., Prestidge R.L., Palmer D.J., Watson J.D., Kumble K.D. B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR alpha-chemokine. Int. Immunol. 12:2000;677-689
74. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA. 98:2001;10869-10874
75. St Croix B., Rago C., Velculescu V., Traverso G., Romans K.E., Montgomery E., Lal A., Riggins G.J., Lengauer C., Vogelstein B., Kinzler K.W. Genes expressed in human tumor endothelium. Science. 289:2000;1197-1202
76. Sternlicht M.D., Barsky S.H. The myoepithelial defense. a host defense against cancer Med. Hypotheses. 48:1997;37-46
77. Sternlicht M.D., Kedeshian P., Shao Z.M., Safarians S., Barsky S.H. The human myoepithelial cell is a natural tumor suppressor. Clin. Cancer Res. 3:1997;1949-1958
78. Tamamura H., Hori A., Kanzaki N., Hiramatsu K., Mizumoto M., Nakashima H., Yamamoto N., Otaka A., Fujii N. T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer. FEBS Lett. 550:2003;79-83
79. Tanaka K., Sano K., Yuba K., Katsumura K., Nakano T., Kobayashi M., Ikeda T., Abe M. Inhibition of induction of myofibroblasts by interferon gamma in a human fibroblast cell line. Int. Immunopharmacol. 3:2003;1273-1280
80. Tlsty T.D. Stromal cells can contribute oncogenic signals. Semin. Cancer Biol. 11:2001;97-104
81. Tlsty T.D., Hein P.W. Know thy neighbor. stromal cells can contribute oncogenic signals Curr. Opin. Genet. Dev. 11:2001;54-59
82. van 't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415:2002;530-536
83. van de Vijver M.J., He Y.D., van 't Veer L.J., Dai H., Hart A.A., Voskuil D.W., Schreiber G.J., Peterse J.L., Roberts C., Marton M.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347:2002;1999-2009
84. Velculescu V.E., Zhang L., Vogelstein B., Kinzler K.W. Serial analysis of gene expression. Science. 270:1995;484-487
85. Waldman F.M., DeVries S., Chew K.L., Moore D.H. 2nd, Kerlikowske K., Ljung B.M. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J. Natl. Cancer Inst. 92:2000;313-320
86. Walter-Yohrling J., Pratt B.M., Ledbetter S., Teicher B.A. Myofibroblasts enable invasion of endothelial cells into three-dimensional tumor cell clusters. a novel in vitro tumor model Cancer Chemother. Pharmacol. 52:2003;263-269
87. Wernert N., Locherbach C., Wellmann A., Behrens P., Hugel A. Presence of genetic alterations in microdissected stroma of human colon and breast cancers. Anticancer Res. 21:2001;2259-2264
88. Wiseman B.S., Werb Z. Stromal effects on mammary gland development and breast cancer. Science. 296:2002;1046-1049
89. Xiao G., Liu Y.E., Gentz R., Sang Q.A., Ni J., Goldberg I.D., Shi Y.E. Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells. Proc. Natl. Acad. Sci. USA. 96:1999;3700-3705
90. Zhang R.R., Man Y.G., Vang R., Saenger J.S., Barner R., Wheeler D.T., Liang C.Y., Vinh T.N., Bratthauer G.L. A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers. Breast Cancer Res. 5:2003;R151-R156
91. Zhu G., Reynolds L., Crnogorac-Jurcevic T., Gillett C.E., Dublin E.A., Marshall J.F., Barnes D., D'Arrigo C., Van Trappen P.O., Lemoine N.R., Hart I.R. Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer. Oncogene. 22:2003;3742-3748